News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

First-line pembrolizumab feasible for BRAF V600–mutant melanoma
10 Nov 2022
A recent study recommends the use of pembrolizumab over BRAF/mitogen-activated protein kinase inhibitors, such as dabrafenib/trametinib, as first-line treatment in patients with advanced BRAF V600‒mutant advanced malignant melanoma.
10 Nov 2022

AF does not reduce dapagliflozin efficacy in HF patients
10 Nov 2022
byStephen Padilla
The presence of atrial fibrillation (AF) at baseline does not appear to modify the benefits of dapagliflozin, compared with placebo, on symptoms and clinical events in patients with heart failure and preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF), according to a study.
10 Nov 2022

COVID-19 vaccine for children below 5 years: most parents still hesitant
10 Nov 2022
byAudrey Abella
Widespread hesitancy around COVID-19 vaccination in children below 5 years does exist, even among parents showing preference for vaccinating their child in this age group, a US study suggests.
10 Nov 2022





